Meeting
2016 Gastrointestinal Cancers Symposium
Effect of combined neoadjuvant chemoradiation on overall survival for patients with locally advanced rectal cancer.
Authors
Zhifei Sun
Duke University Medical Center, Durham, NC
Zhifei Sun , Mohamed A Adam , Jina Kim , Shiao-Wen D Hsu , Manisha Palta , Brian G. Czito , John Migaly , Christopher Mantyh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 657)
DOI
10.1200/jco.2016.34.4_suppl.657
Abstract #
657
Poster Bd #
H18
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Neoadjuvant short-course radiotherapy followed by chemotherapy plus camrelizumab versus long-course chemoradiotherapy followed by chemotherapy for patients with locally advanced rectal cancer: A randomized, multicenter, open-label phase 3 trial (Union).
First Author: Zhenyu Lin
Poster
2017 Gastrointestinal Cancers Symposium
Systemic chemotherapy (CT) as salvage treatment for locally advanced rectal cancer (LARC) patients (pts) who fail to respond to neoadjuvant chemoradiotherapy (CRT).
First Author: Francesco Sclafani
Poster
2016 Gastrointestinal Cancers Symposium
Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after neoadjuvant chemoradiation therapy.
First Author: Chang-gon Kim
Poster
2015 Gastrointestinal Cancers Symposium
Matched pair analysis of sequential short course radiotherapy and FOLFOX chemotherapy as preoperative therapy for rectal cancer compared to neoadjuvant long course chemoradiotherapy.
First Author: Fady Youssef